Education
About Us
Working with TipRanks
Follow Us
Paradigm Medical (PDMI)
OTHER OTC:PDMI
PDMI Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume7.50K
Average Volume (3M)N/A
Market Cap
$3.25K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-36.20
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,248,785,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PDMI FAQ
What was Paradigm Medical’s price range in the past 12 months?
Paradigm Medical lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Paradigm Medical’s market cap?
Paradigm Medical’s market cap is $3.25K.
When is Paradigm Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Paradigm Medical’s earnings last quarter?
Currently, no data Available
Is Paradigm Medical overvalued?
According to Wall Street analysts Paradigm Medical’s price is currently Overvalued.
Does Paradigm Medical pay dividends?
Paradigm Medical does not currently pay dividends.
What is Paradigm Medical’s EPS estimate?
Paradigm Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Paradigm Medical have?
Paradigm Medical has 3,248,785,000 shares outstanding.
What happened to Paradigm Medical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Paradigm Medical?
Currently, no hedge funds are holding shares in PDMI
Company Description
Paradigm Medical
Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company offers P-2000 biometric analyzer A-scans and P-2500 A-scans/pachymeters; P2700 A/B and P37-II A/B scans; blood flow analyzers for the detection and management of glaucoma and other retinal vascular disorders; P2200 pachymeter and P-2500 A-scan/pachymeters; and LD 500 and LD700 autoperimeters. It also provides corneal topographers, such as PARAVUE 300 for diagnostic and contact lens applications, as well as SURVEYOR 500 for cornea and anterior segment; PARAMAX, which analyzes the functionality of ganglion cells and identifies glaucoma suspects; P60 and P60 ACI ultrasound biomicroscopes; and PARACAM 1000, a non-contact endothelial microscope, as well as software and accessories. The company was founded in 1989 and is based in Salt Lake City, Utah.
Milestone Scientific
―
GlucoTrack
―
Femasys
―
Meihua International Medical Technologies Co., Ltd.
―
Sharps Technology, Inc.
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---